MOSES raises questions
- PMID: 16397172
- DOI: 10.1161/01.STR.0000199643.05768.8f
MOSES raises questions
Comment on
-
Morbidity and Mortality After Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention: principal results of a prospective randomized controlled study (MOSES).Stroke. 2005 Jun;36(6):1218-26. doi: 10.1161/01.STR.0000166048.35740.a9. Epub 2005 May 5. Stroke. 2005. PMID: 15879332 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
